Phase I Open Label Liver-Directed Gene Therapy Clinical Trial for Acute Intermittent Porphyria

Journal of Hepatology - Netherlands
doi 10.1016/j.jhep.2016.05.012
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Elsevier BV

Related search

Gene Therapy for Rare Diseases – The Case for Acute Intermittent Porphyria

EPMA Journal
BiochemistryHealth PolicyDrug Discovery
2014English

Acute Intermittent Porphyria

JAMA - Journal of the American Medical Association
Medicine
1962English

Gene Therapy for Pain: Results of a Phase I Clinical Trial

Annals of Neurology
Neurology
2011English

Acute Intermittent Porphyria Studies With Fibroblasts.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1970English

Studies in Porphyria: I. A Defect in the Reductive Transformation of Natural Steroid Hormones in the Hereditary Liver Disease, Acute Intermittent Porphyria

Journal of Experimental Medicine
MedicineAllergyImmunology
1972English

Family Evaluations in Acute Intermittent Porphyria Using Red Cell Uroporphyrinogen I Synthetase.

Journal of Medical Genetics
Genetics
1979English

Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria

Frontiers in Pharmacology
Pharmacology
2019English

Acute Intermittent Porphyria and Phaeochromocytoma: Shared Features

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Acute Intermittent Porphyria in Childhood: A Neglected Diagnosis?

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1975English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy